These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16061015)

  • 1. [Invasive fungal infection: challenge and choice].
    Weng XH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1441-2. PubMed ID: 16061015
    [No Abstract]   [Full Text] [Related]  

  • 2. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
    Wang CY; Wu BY; Guo KY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing fungal infections in chronic granulomatous disease.
    Verweij PE; Warris A; Weemaes CM
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 14503544
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing fungal infections in chronic granulomatous disease.
    Berger VW
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 13679539
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing fungal infections in chronic granulomatous disease.
    Franzblau MJ
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 14503545
    [No Abstract]   [Full Text] [Related]  

  • 7. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of entomophthoromycosis with itraconazole.
    Kabra SK; Jain Y; Sudhin T; Iyer KV; Ninan SA; Seth V
    Indian Pediatr; 1998 Feb; 35(2):163-6. PubMed ID: 9707860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
    Shen ZX; Chen QS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1447-8. PubMed ID: 16061018
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal rhinosinusitis in Maharaj Nakorn Chiang Mai Hospital.
    Roongrotwattanasiri K; Fooanant S; Naksane L
    J Med Assoc Thai; 2007 Nov; 90(11):2524-8. PubMed ID: 18181345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
    Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    Whittle AM; Ali S
    Int J Lab Hematol; 2008 Apr; 30(2):173-4. PubMed ID: 18333850
    [No Abstract]   [Full Text] [Related]  

  • 18. Misleading statements in industry-sponsored meta-analysis of itraconazole.
    Gøtzsche PC; Johansen HK
    J Clin Oncol; 2005 Dec; 23(36):9428-9; author reply 9429-32. PubMed ID: 16361645
    [No Abstract]   [Full Text] [Related]  

  • 19. [The future of antifungal agents].
    Maesaki S
    Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
    [No Abstract]   [Full Text] [Related]  

  • 20. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.